Gemma Fuster

6PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersMolecular targetsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 19, 2024
Predictive capacity for local disease control of neogenin-1 (NEO1) transcriptional expression in patients with head and neck squamous cell carcinoma.

Xavier León, Cristina Valero, Gemma Fuster

|Apr 28, 2023
In Vitro and In Vivo Effects of the Combination of Polypurine Reverse Hoogsteen Hairpins against HER-2 and Trastuzumab in Breast Cancer Cells.

Ester López-Aguilar, Patricia Fernández-Nogueira, Gemma Fuster

|May 14, 2022
Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC.

Carla Meler-Claramonte, Francesc Xavier Avilés-Jurado, Isabel Vilaseca

|Nov 09, 2019
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation.

Patricia Fernández-Nogueira, Mario Mancino, Gemma Fuster

|Jul 06, 2018
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis.

Arantzazu Zubeldia-Plazaola, Leire Recalde-Percaz, Núria Moragas

Pageof 1